Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Psychiatry Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Psychiatry Other
    Parent Training Complements Medication for Treating Children With Pervasive Developmental Disorders - (DGNews)
    Psychotropic Medications Associated With Risk of Falls in Older Adults - (DGNews)
    FDA Approves Aripiprazole to Treat Irritability Associated With Autistic Disorder - (DGNews)
    FDA Approves Ziprasidone for Adjunctive Maintenance Treatment of Bipolar Disorder - (DGNews)
    Aripiprazole Generally Safe, Tolerable for Children With Autism-Related Irritability: Presented at AACAP - (DGDispatch)

    News archive

     Recent webcasts/CME - Psychiatry Other

    Webcasts/CME archive

     Recent cases - Psychiatry Other
      Munchausen Syndrome In The Emergency Department Mostly Difficult, Sometimes Easy To Diagnose: A Case Report And Review Of The Literature
      Female Sexual Dysfunction as a Comorbid Illness
      11p Microdeletion Including WT1 but not PAX6, Presenting with Cataract, Mental Retardation, Genital Abnormalities and Seizures: Case Report
      Comorbidity of Asperger's Syndrome and Bipolar Disorder
      Psychiatric Disorder Associated with Vacuum-Assisted Breast Biopsy Clip Placement: A Case Report

      Cases archive
        




      my personal edition > psychiatry other > news
      divider

        E-Mail this DGDispatch to a colleague

      DGDispatch


      Venlafaxine Equals Paroxetine for Obsessive-Compulsive Disorder: Presented at APA

      By Bruce Sylvester

      PHILADELPHIA, PA -- May 21, 2002 -- Effexor (venlafaxine) appears to be equally effective to Paxil (paroxetine) for the treatment of obsessive-compulsive disorder (OCD), researchers report.

      The results from the first randomized, double-blind, head-to-head study comparing the two drugs for the treatment of OCD were presented here on May 20 at the annual meeting of the American Psychiatric Association (APA).

      "We wanted to find out how a compound acting on two different brain systems -- serotonin and norepinephrine -- compared in OCD treatment to a compound acting only on serotonin" said lead researcher Harold Van Megen, MD, associate professor of medicine, University of Utrecht, Netherlands. "We found the efficacy of each drug to be comparable."

      Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI) and paroxetine is a selective serotonin reuptake inhibitor (SSRI).

      The researchers recruited 150 subjects with primary OCD, according to Diagnostic and Statistical Manual IV (DSM-IV) criteria. In the 12-week trial, they randomly assigned 74 subjects to receive dosages titrated upward to 300 mg/day of venlafaxine and 76 to receive 60 mg/day of paroxetine.

      Efficacy of treatment was assessed according to changes from baseline on the Yale-Brown obsessive-compulsive scale (Y-BOCS). They defined a clinical response as a decrease of 25 percent on the Y-BOCS. They also made assessments with the Hamilton depression rating scale and Hamilton anxiety rating scale.

      The researchers found a 60 percent positive response in both groups of subjects. There was a mean decrease on the Y-BOCS of 30±29.5 percent in the venlafaxine group and of 30±26 percent in the paroxetine group.

      "The take-home message here is about an alternative for patients experiencing difficult side effects on paroxetine," Dr. Van Megan said. "If an OCD patient has side effect problems with paroxetine, we can now say that a switch to venlafaxine could be equally efficacious for OCD treatment."



      E-Mail this DGDispatch to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send